Atlas Trials

Study to Determine D-amino Acid Oxidase Brain Enzyme Occupancy of TAK-831 After Single-dose Oral Administration

Clinical trial NCT02716987 · COMPLETED

Trial details

NCT number
NCT02716987
Sponsor
Neurocrine Biosciences
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2016-03-21
Primary completion
2016-08-30
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.